AAROGYAAI
AarogyaAI is an artificial intelligence-based software as a service that diagnoses drug-resistant tuberculosis. AarogyaAI uses a DNA sequence from the patient which is uploaded to SaaS. Its machine-learning algorithm then gives an output report of a comprehensive drug susceptibility status of the patient.
AAROGYAAI
Industry:
Artificial Intelligence Health Care Machine Learning SaaS Software
Founded:
2019-05-31
Address:
New Delhi, Delhi, India
Country:
India
Website Url:
http://www.aarogya.ai
Total Employee:
1+
Status:
Active
Total Funding:
855.52 K USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Font Awesome Wordpress Plugins Nginx
Similar Organizations
AccutarBio
AccutarBio employs artificial intelligence to revolutionize drug discovery.
Artrya
Artrya uses artificial intelligence to deliver faster and more accurate diagnoses of Coronary Artery Disease.
Cognism
Cognism is a B2B sales acceleration software company that provides a marketing and sales acceleration solution.
Navina
Navina develops an AI-driven platform that restructures patient data into intuitive patient portraits for better diagnoses and care.
Pateo
Pateo uses artificial intelligence to provide automobile solutions.
Actium Health
Actium provides consumer engagement utilizing health-system data intelligence.
togetherAI
TogetherAI helps protect kids online and supports families to connect and communicate about mental health and well-being.
TUNGEE
Tungee is a professional sales intelligence solution provider.
Current Employees Featured
Founder
Investors List
Entrepreneur First
Entrepreneur First investment in Seed Round - AarogyaAI
Redstart Labs
Redstart Labs investment in Seed Round - AarogyaAI
First In Ventures
First In Ventures investment in Seed Round - AarogyaAI
Avaana Capital
Avaana Capital investment in Seed Round - AarogyaAI
First In Ventures
First In Ventures investment in Pre Seed Round - AarogyaAI
Entrepreneur First
Entrepreneur First investment in Pre Seed Round - AarogyaAI
Official Site Inspections
http://www.aarogya.ai Semrush global rank: 8.15 M Semrush visits lastest month: 359
- Host name: server-3-167-37-83.iad61.r.cloudfront.net
- IP address: 3.167.37.83
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "AarogyaAI"
About Us - Learn more our vision and team here - Aarogya
AI helps unearth future drug resistance patterns to preemptively plan actions and combat the next pandemic. Starting out in 2019, the focus was on effective diagnosis of Drug-Resistant …See details»
AarogyaAI - Crunchbase Company Profile & Funding
AarogyaAI is an artificial intelligence-based software as a service that diagnoses drug-resistant tuberculosis. AarogyaAI uses a DNA sequence from the patient which is uploaded to SaaS. Its …See details»
AarogyaAI - 2025 Company Profile - Tracxn
AarogyaAI - Cloud and AI-enabled software for diagnosing drug-resistant tuberculosis. Raised a total funding of $754K over 3 rounds from 11 investors. …See details»
AarogyaAI 2025 Company Profile: Valuation, Funding …
The company's platform uses artificial intelligence to perform a quick and accurate diagnosis of drug-resistant infections in a few hours, enabling …See details»
AarogyaAI® - AI Powered Healthcare & Diagnostics Solutions
Powered by artificial intelligence and machine learning, AarogyaAI®’s products rapidly and accurately diagnose drug resistance, enabling clinicians to make data-driven treatment …See details»
AarogyaAI Company Profile Funding & Investors
Aarogya.AI will also be developing tests for other anti-microbial diseases such as urinary tract infection and cholera in the next phase of growth for the company. Legal Name AarogyaAI Innovations ...See details»
AarogyaAI | Portfolio | Entrepreneurs First
AarogyaAI enables precision medicine for anti-microbial resistance in infectious disease by unlocking the power of genomics and artificial intelligence. Tuberculosis is the most lethal …See details»
AarogyaAI - Products, Competitors, Financials, Employees, …
India based AI-enabled Healthtech startup AarogyaAI raises USD 700K in seed round. Jan 8, 2022. India based AI-enabled Healthtech startup AarogyaAI raises USD 700K in seed round …See details»
AarogyaAI - Extreme Tech Challenge
Jan 7, 2022 AarogyaAI aims to diagnose drug-resistant tuberculosis (DR-TB) using Artificial Intelligence, which enables quick and accurate diagnosis of DR-TB in just a few hours. With quick diagnoses, patients can be prescribed drug …See details»
AarogyaAI-Revolutionising the Diagnosis of TB - IIT …
Nov 2, 2022 Building the pipeline - bioinformatics - AI - ML and looking for the model that was best suited to compute the data set was a laborious process. Interestingly, this startup has developed its model using a unique way of …See details»
AarogyaAI - Overview, News & Similar companies | ZoomInfo.com
Jan 7, 2022 Founded in 2019 and headquartered in Bengaluru, India, AarogyaAI aims to diagnose drug-resistant TB (DR-TB) using artificial intelligence in a few hours. We enable …See details»
Aarogya ID
Process 10x more claims with AI Agents. Process 10x more claims with AI Agents ... Let our technology seamlessly manage backend tasks for efficient medical record organization. 3. …See details»
Aarogya - Crunchbase Company Profile & Funding
Aarogya is a health portal and app, providing health information and services, including COVID-19 vaccination scheduling. ... Experience the new Crunchbase, powered by AI . Organization. …See details»
AarogyaAI - Raised $754K Funding from 11 investors - Tracxn
6 days ago AarogyaAI has raised a total funding of $754K over 3 rounds from 11 investors. Investors include Illumina, Entrepreneur First and 9 others. Their latest funding round was of …See details»
AarogyaAI uses AI/ML on AWS to precisely diagnose antimicrobial ...
Aarogya AI uses AWS managed services like SageMaker, Amazon Relational Database Service (Amazon RDS), and Elastic Load Balancing to complete tasks that would otherwise be …See details»
Newsroom, AarogyaAI®, harnesses technology for precision …
Jul 24, 2019 AarogyaAI uses AI/ML on AWS to precisely diagnose antimicrobial resistance June 6, 2023. Meet the most promising ML startups selected for this year’s cohort at ML Elevate …See details»
Trust in AI-assisted health systems and AI’s trust in humans
3 days ago Yet despite the boom in medical AI—1016 AI devices have been cleared by the U.S. Food and Drug Administration for clinical use as of September 2024 1 —hesitancy about …See details»
Arogya.ai - LinkedIn
Arogya.ai | 1,054 followers on LinkedIn. Transforming businesses through Data, Information, Intelligence, Insights, and AUTOMATION! | Arogya.ai is an innovative strategic technology …See details»
Designed for precision diagnosis of AMR - Aarogya
Our products unlock the pathogen genome and harness artificial intelligence (AI) for the precision diagnosis of AMR 1. in 50 deaths in 2019, were attributed directly to drug-resistant infections. …See details»
From regulations to open-source: What AI Alliance members want …
Jun 21, 2024 When more than 50 tech companies, universities and startups from around the world united to form the AI Alliance last December, much of the globe was still making sense …See details»